Budget Crunch Forces CDRH To Abbreviate Baseline Device GMP Inspections
This article was originally published in The Gray Sheet
Executive Summary
CDRH plans to dramatically increase its inspections of domestic medical device facilities performed this year by reviewing only two of the four major QSIT subsystems in each "baseline" audit.
You may also be interested in...
QS Corrections & Removals Require Strong Customer Advocacy – Exec
Creation of a multi-discipline "customer advocacy team" to handle all non-sales calls can help device firms foresee and prepare for potential product or quality system problems, Alaris Medical Systems VP-Quality & Regulatory Affairs Bill Murphy suggested at RAPS' recent medical device conference
QS Corrections & Removals Require Strong Customer Advocacy – Exec
Creation of a multi-discipline "customer advocacy team" to handle all non-sales calls can help device firms foresee and prepare for potential product or quality system problems, Alaris Medical Systems VP-Quality & Regulatory Affairs Bill Murphy suggested at RAPS' recent medical device conference
CDRH Mulls Alternative Inspection Methods, Random-Sampling Audits
FDA expects to begin auditing randomly selected manufacturers of low risk devices by the first quarter of 2002, FDA staffers suggest following submission of the proposal to the Office of Regulatory Affairs.